Pascal Haenggi

Pascal is a co-founder and Chief Scientific Officer of Polyneuron. Since the company’s foundation, Pascal has been instrumental in delivering on key company milestones in preclinical drug development, the management of contract research activities, and the interaction with health authorities. He holds a M.Sc. in Pharmaceutical Sciences from the University of Basel and completed his Ph.D. at the University of Zürich in Molecular Medicine.